Discussing Professor Yin Kejing’s Drug Use Law for Mammary Hyperplasia Based on Data Mining Technology

Weiwei Xu, Wenjing Hu, Kejing Yin, Xu DuInternational Journal of Clinical and Experimental Medicine Research 2021 · DOI

Abstract

This study explores the drug use characteristics and underlying logic of Professor Yin Kejing, a master of Traditional Chinese Medicine (TCM), in treating mammary hyperplasia (MH). By analyzing 80 clinical prescriptions using Excel-based databases, association rule mining, and cluster analysis, the research identifies core herbal combinations and pharmacological properties. Results indicate that Astragalus membranaceus (Huangqi) is the foundational herb, with a primary focus on the liver meridian and a "bitter-warm" therapeutic strategy. Three distinct herbal clusters were identified, providing a standardized framework for treating MH through Qi activation and blood stasis removal.

Introduction

Mammary hyperplasia (MH) is a prevalent benign breast condition, affecting up to 75% of women in certain clinical populations. Characterized by pain and physical masses, it carries a significant risk of malignant transformation if left untreated. In TCM, MH is typically attributed to "liver qi depression" and "blood stasis." However, the complexity of master-level prescriptions often obscures the underlying therapeutic "law." This paper utilizes data mining to decode the clinical expertise of Professor Yin Kejing, bridging the gap between traditional intuition and evidence-based standardization.

Methodology

The researchers conducted a retrospective analysis of 80 clinical prescriptions collected between October and December 2020 at the Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine. The dataset involved 170 unique herbs and 1,784 individual uses.

Data processing involved:

  1. Frequency Analysis: Identifying the most common herbs, "Four Qi" (temperature), "Five Flavors," and "Meridian Tropism."
  2. Association Rule Mining: Using Weka 3.6.9 and SPSS Modeler to identify high-confidence herbal pairings (minimum 80% confidence).
  3. Cluster Analysis: Utilizing dendrograms to group herbs into synergistic clusters.

Results and Analysis

Core Herbal Properties and Tropism

The analysis revealed a strong preference for herbs targeting the Foot Yin Liver Meridian (1,040 instances), reinforcing the TCM link between breast health and liver function. The dominant therapeutic properties were "Bitter" flavors (32.75%) and "Warm" temperatures (46.24%), suggesting a strategy of aggressively breaking down masses while invigorating circulation.

Network Association Mapping

Astragalus membranaceus (Huangqi) appeared in 100% of the prescriptions, serving as the essential "Qi-supplementing" foundation. The network diagram illustrates the high-density associations between Huangqi and other core herbs like Radix Paeoniae Alba and Angelica sinensis.

Network association diagram of high-frequency herbs used in the treatment of mammary hyperplasia.

Cluster Analysis and Synergistic Groups

Cluster analysis identified three primary "new combinations" that represent the core of Professor Yin’s treatment logic:

  • Cluster 1: Focuses on supplementing Qi and nourishing blood (Astragalus + Radix Paeoniae).
  • Cluster 2: Focuses on resolving phlegm and relieving pain (White mustard + Corydalis).
  • Cluster 3: Focuses on moving Qi and breaking stasis (Curcuma + Chimonanthus).
Dendrogram showing the hierarchical clustering of herbs into effective treatment groups.

Discussion and Conclusion

The data mining results suggest that Professor Yin’s "Drug Use Law" for mammary hyperplasia is centered on the principle of "treating both specimens"—simultaneously addressing the root cause (Qi deficiency) and the manifestation (blood stasis and masses). By supplementing Qi with Huangqi, the "pushing" force of the blood is increased, allowing secondary herbs to effectively resolve stasis in the liver meridian.

While the sample size of 80 cases is relatively small, the high confidence levels in association rules (such as the 100% confidence between Wintersweet Flower and Curcuma) provide a robust starting point for clinical standardization. Future work should correlate these herbal clusters with specific patient outcomes to verify clinical efficacy in controlled trials.

Summary updated

Abstract

Objective: To explore the drug use characteristics and rules of Professor Yin Kejing in the treatment of mammary hyperplasia. Methods: Select the clinical prescription of traditional Chinese medicine for mammary hyperplasia in the past three months, establish a prescription database for traditional Chinese medicine treatment mastosis by using Excel software, use the relevant rule method and cluster analysis in data mining technology, and summarize the characteristics and rules of prescription drugs for traditional Chinese medicine. Results: A total of 80 prescriptions of traditional Chinese medicine were included, involving 170 flavors of traditional Chinese medicine, and the total frequency of use of traditional Chinese medicine was 1,784 times. Among them, the most frequently used traditional Chinese medicine, meridian, four qi and five flavors were Huangqi (80 times), foot yin liver meridian (1,040), temperature (825 times) and bitterness (938 times). The correlation analysis results show that the most supportive combination of traditional Chinese medicine is tulips and plum blossoms. The cluster analysis results show that there are three effective cluster groups. It can be concluded that the drug used to treat mammary hyperplasia is mainly qi-activating blood, supplements qi and blood, treats both specimens, and qi and removes blood stasis. Clinically, the combination of Huangqi-Peonyeoniae-leaked reed-Rebuilding, white mustard-Yanhusuo, and tulips-Zlum flower can be used, and can be dialectically treated according to different clinical classifications.
BibTeX
@article{xu2021discussing,
  author = {Weiwei Xu and Wenjing Hu and Kejing Yin and Xu Du},
  title = {{Discussing Professor Yin Kejing’s Drug Use Law for Mammary Hyperplasia Based on Data Mining Technology}},
  journal = {International Journal of Clinical and Experimental Medicine Research},
  year = {2021},
  doi = {10.26855/ijcemr.2021.07.026},
}
Figure